603259 藥明康德
按盤價 
-- -- (--) | 2026/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 12,435,777 | 28.81% | 45,456,166 | 39,241,431 | 40,340,807 | 39,354,778 | |
| 減：營業總成本 | 7,433,446 | 10.75% | 29,148,155 | 27,342,268 | 28,708,591 | 29,800,811 | |
| 其中:營業成本 | 6,167,823 | 10.64% | 23,801,435 | 22,964,515 | 23,728,800 | 24,677,217 | |
| 財務費用 | 14,682 | -79.50% | 398,191 | (786,684) | (338,119) | (247,968) | |
| 資產減值損失 | (41,177) | -73.64% | (541,556) | (1,236,258) | (156,509) | (175,951) | |
| 公允價值變動收益 | 459,261 | -1,099.73% | (137,098) | 186,958 | (37,809) | 770,079 | |
| 投資收益 | 164,837 | -89.28% | 8,588,017 | 604,162 | 233,849 | 187,949 | |
| 其中：對聯營企業和合營企業的投資收益 | 138,966 | 117.13% | 452,582 | 245,065 | (67,560) | (46,271) | |
| 營業利潤 | 5,614,937 | 30.80% | 23,930,084 | 11,580,175 | 11,872,286 | 10,652,249 | |
| 利潤總額 | 5,607,280 | 31.01% | 23,906,151 | 11,539,812 | 11,831,991 | 10,618,476 | |
| 減：所得稅費用 | 936,766 | 65.97% | 4,573,085 | 1,972,072 | 2,131,731 | 1,715,866 | |
| 淨利潤 | 4,670,514 | 25.70% | 19,333,066 | 9,567,740 | 9,700,260 | 8,902,611 | |
| 減：非控股權益 | 18,996 | -56.34% | 182,483 | 117,431 | 93,511 | 88,898 | |
| 股東淨利潤 | 4,651,518 | 26.68% | 19,150,582 | 9,450,308 | 9,606,749 | 8,813,713 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.590 | 23.26% | 6.700 | 3.280 | 3.270 | 3.010 | |
| 每股派息 (元) * | -- | -- | 2.279 | 0.982 | 0.990 | 0.893 | |
| 每股淨資產 (元) * | 28.227 | 30.78% | 26.715 | 20.302 | 18.570 | 15.737 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 08/05/2026 08:03 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
